ArticleFrontiers in immunology2025

The impact of β-blockers on outcomes of immune checkpoint inhibitors therapy in advanced lung cancer: a multicenter real-world study.

Lingdan Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.